Why Deutsche Bank, Intra-Cellular Therapies, and Coherus BioSciences Slumped TodayThe Motley Fool • 07/08/19
Intra-Cellular Therapies stock down 15% after disappointing Phase 3 trial resultsMarket Watch • 07/08/19
Intra-Celluar Therapies Falls Following Results For Treatment Of Bipolar DepressionBenzinga • 07/08/19
Intra-Cellular announces positive results in late-stage trials of treatment for bipolar depressionMarket Watch • 07/08/19
Intra-Cellular Therapies Inc. (ITCI) CEO Sharon Mates on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/08/19